Microneedle Medical Device CDMO

Technology Principle

Microneedle arrays typically use 300–700 μm structures to penetrate or loosen the stratum corneum and create temporary microchannels that improve local delivery efficiency.

Application Directions

Potential product pathways include dermatology, aesthetic aftercare, local pain management and drug-device combinations.

• Dermatology and localized permeation
• Aesthetic and post-procedure care
• Local pain and joint care
• Microneedle plus topical drug, gel or functional dressing

Regulatory Pathway

The appropriate pathway depends on product risk, mechanism, depth of action and intended use. CASMN can support early classification and registration-strategy assessment.

Cooperation Models

Projects can be structured around a client-held marketing authorization, commissioned R&D, contract manufacturing, or customized supply under an appropriate CASMN-held authorization where applicable.

Delivery Scope

Services may include concept and product design, prototype preparation, process development, registration support, process validation and scale manufacturing.